Inhibition of inducible nitric oxide synthase in vitro and in vivo by a water-soluble extract of Wendita calysina leaves

被引:0
|
作者
Stefania Marzocco
Anna Lisa Piccinelli
Luca Rastrelli
Emanuela Mazzon
Salvatore Cuzzocrea
Giuseppina Autore
机构
[1] University of Salerno,Department of Pharmaceutical Sciences, School of Pharmacy
[2] University of Messina,Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine
[3] IRCCS Centro Neurolesi “Bonino-Pulejo”,undefined
关键词
leaves; Phenylpropanoid glycosides; Inducible nitric oxide synthase (iNOS); J774.A1 macrophages; Carrageenan-induced pleurisy;
D O I
暂无
中图分类号
学科分类号
摘要
Wendita calysina is a Paraguayan herbaceous plant commonly known as burrito. Our previous study indicated that burrito leaves are a very good source of phenylpropanoid glycosides, principally verbascoside. From W. calysina leaves, a standardized, water-soluble extract (WSE) rich in phenylpropanoid glycosides has been developed on an industrial scale to be used as a food supplement, cosmetic, phytomedicine, and ingredient of different formulations. In this study, we investigated the effect of the W. calysina WSE both in vitro in murine macrophage cell line J774.A1 stimulated with lipopolysaccharide (LPS) and, in vivo in an animal model of acute inflammation, carrageenan-induced pleurisy. Here we report that W. calysina WSE (0.05, 0.1, and 0.5 mg/ml) inhibited inducible nitric oxide synthase (iNOS) expression and activity in LPS-stimulated J774.A1. In vivo experiments showed that injection of carrageenan (2%) into the pleural cavity of rats elicited an acute inflammatory response characterized by iNOS expression, intercellular adhesion molecule-1 (ICAM-1) up-regulation, nitrotyrosine and poly (ADP-ribose) synthase (PARS) formation, and lung tissue damage—all parameters significantly reduced by W. calysina WSE (500 mg/kg per os). These results report, for the first time, that a treatment with W. calysina WSE exerts anti-inflammatory effects both in vitro and in vivo.
引用
收藏
页码:349 / 358
页数:9
相关论文
共 50 条
  • [31] Endothelial nitric oxide synthase deficiency and inducible nitric oxide synthase inhibition in the setting of septic cardiomyopathy
    A Van de Sandt
    R Windler
    A Gödecke
    J Ohlig
    S Becher
    E Van Faassen
    T Rassaf
    J Schrader
    M Kelm
    M Merx
    Critical Care, 13 (Suppl 1):
  • [32] Induction of nitric oxide synthase in vivo and cell injury in rat duodenal epithelium by a water soluble extract of Helicobacter pylori
    Lamarque, D
    Kiss, J
    Tankovic, J
    Flejou, JF
    Delchier, JC
    Whittle, BJR
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (06) : 1073 - 1078
  • [33] In vivo detection of inducible nitric oxide synthase in rodent gliomas
    Towner, Rheal A.
    Smith, Nataliya
    Doblas, Sabrina
    Garteiser, Philippe
    Watanabe, Yasuko
    He, Ting
    Saunders, Debra
    Herlea, Oana
    Silasi-Mansat, Robert
    Lupu, Florea
    FREE RADICAL BIOLOGY AND MEDICINE, 2010, 48 (05) : 691 - 703
  • [34] Role of inducible nitric oxide synthase in leukocyte extravasation in vivo
    Cockrell, A
    Laroux, FS
    Jourd'heuil, D
    Kawachi, S
    Gray, L
    Van der Heyde, H
    Grisham, MB
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (03) : 684 - 686
  • [35] In vivo expression of inducible nitric oxide synthase in cerebellar neurons
    MincGolomb, D
    Yadid, G
    Tsarfaty, I
    Resau, JH
    Schwartz, JP
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 (04) : 1504 - 1509
  • [36] Effect of 7-nitroindazole and related indazoles on inducible nitric oxide synthase in vitro and in vivo
    McLoughlin, CM
    Moore, PK
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 : U63 - U63
  • [37] Translational control of inducible nitric oxide synthase in vitro and in vivo during Leishmania major infection
    Schleicher, U
    Koenig, T
    Bogdan, C
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2006, 14 (04): : A1 - A2
  • [38] The inhibition of inducible nitric oxide synthase in ovine sepsis model
    Enkhbaatar, P
    Murakami, K
    Traber, LD
    Cox, R
    Parkinson, JF
    Westphal, M
    Esechie, A
    Morita, N
    Maybauer, MO
    Maybauer, DM
    Burke, AS
    Schmalstieg, FC
    Hawkins, HK
    Rndon, DNH
    Traber, DL
    SHOCK, 2006, 25 (05): : 522 - 527
  • [39] PREFERENTIAL INHIBITION OF INDUCIBLE NITRIC-OXIDE SYNTHASE BY EBSELEN
    HATTORI, R
    INOUE, R
    SASE, K
    EIZAWA, H
    KOSUGA, K
    AOYAMA, T
    MASAYASU, H
    KAWAI, C
    SASAYAMA, S
    YUI, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 267 (02): : R1 - R2
  • [40] Selective inducible nitric oxide synthase inhibition in septic shock
    Beilman, GJ
    CRITICAL CARE MEDICINE, 2001, 29 (11) : 2230 - 2231